Rosalia Bellante Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

11/2023	Advanced Hybrid Closed-Loop System Achieves and Maintains Recommended Time in Range Levels for Up To 2 Years: Predictors of Best Efficacy.
1/2023	Real-World Insulin Treatment in Pregnant Women with Type 1 Diabetes Using an Advanced Hybrid Closed-Loop System.
10/2022	Switching to the Minimed™ 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control.
11/2020	Continuous subcutaneous insulin infusion reduces maternal and neonatal risk in pregnant women with type 1 diabetes: An observational cohort study of 122 pregnancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rosalia Bellante Research Topics

Disease

4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2023 - 11/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2020
1	Hypoglycemia (Reactive Hypoglycemia) 11/2023
1	Albuminuria 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Heart Failure 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Pneumonia (Pneumonitis) 12/2020
1	COVID-19 12/2020

Drug/Important Bio-Agent (IBA)

4	Insulin (Novolin)FDA Link 01/2023 - 11/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2023
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	dapagliflozinIBA 01/2022
1	CreatinineIBA 01/2022
1	Sitagliptin Phosphate (Januvia)FDA Link 12/2020
1	Oxygen (Dioxygen)IBA 12/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2020

Therapy/Procedure

2	Glycemic Control 11/2023 - 01/2022